戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n upon miR-200 overexpression toward that of highly metastatic cells.
2 elta levels were relatively increased in the highly metastatic cells.
3  transcripts displaying reduced stability in highly metastatic cells.
4 gainst poorly metastatic cells compared with highly metastatic cells.
5 ignificantly impairs the bone progression of highly metastatic cells.
6 s phosphoinositide 3-kinase, AKT, and SRC in highly metastatic cells.
7 g ligand activation of the EGFR, but only in highly-metastatic cells.
8 ecause they preferentially activate c-Src in highly-metastatic cells.
9              Within minutes of adhesion, the highly metastatic cells acquire the ability of enhanced
10 ere we show that loss of c-KIT expression in highly metastatic cells correlates with loss of expressi
11 at up-regulation of MCAM/MUC18 expression in highly metastatic cells correlates with loss of expressi
12 etastatic variants, suggest that not only do highly-metastatic cells display constitutively elevated
13 ration of miR-10b antagomirs to mice bearing highly metastatic cells does not reduce primary mammary
14                                              Highly metastatic cells evade this tumor-suppressive pat
15 ompared with poorly metastatic cancer cells, highly metastatic cells expressed increased levels of th
16                                              Highly metastatic cells growing in culture constitutivel
17                                              Highly metastatic cells growing in the prostate expresse
18 usly shown that enforced c-KIT expression in highly metastatic cells inhibited tumor growth and metas
19                 Silencing of IL-13Ralpha2 in highly metastatic cells led to a decrease in adhesion ca
20 y a poorly metastatic cell line to that by a highly metastatic cell line 24 h after injection in the
21 -2 mRNA stabilization in MDA-MB-231 cells, a highly metastatic cell line derived from a human mammary
22 ential reversal of oncogenic properties of a highly metastatic cell line with the introduction of non
23 ially expressed (greater than 2-fold) in all highly metastatic cell lines relative to their reference
24                        The undifferentiated, highly metastatic cell lines with high metastatic potent
25                                              Highly metastatic cells (MDA-MB-435) expressing high lev
26            Does it arise from rare, variant, highly metastatic cells or does a primary tumor progress
27               We found that in vivo selected highly metastatic cell populations showed little genetic
28                      Introduction of Psap in highly metastatic cells significantly reduced the occurr
29                               Loss of CC3 in highly metastatic cells such as SCLC might render them r
30                                              Highly metastatic cells survived to produce numerous lun
31                                     When the highly metastatic cells were compared with their low met
32  kinase expression was first demonstrated in highly metastatic cells, whilst re-expression of the pro
33                    The pH at the surfaces of highly metastatic cells within tumors was found to be ab

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。